Sign in Subscribe
Migraine

Migraine: A Debilitating Condition with Growing Research

Strategic Insights

— 1 min read

Migraine is a neurological disorder that affects millions worldwide, causing debilitating pain, nausea, vomiting, and severe fatigue. Despite its prevalence, migraine remains poorly understood, with many misconceptions about its causes and treatments. According to Prof Anne MacGregor, a specialist in headache and women's health at Queen Mary University of London, "Migraine is a brain disorder linked to various inherited gene mutations." Research has identified over 180 gene variants associated with migraine, suggesting a strong genetic component.

Key Takeaways:

  • Migraine affects around 10 million people in the UK, with an annual economic impact of £4.4 billion due to absenteeism from work.
  • Migraine commonly falls into two categories: with and without aura, with aura involving visual or sensory disturbances that can begin before the rest of the migraine symptoms.
  • There are three to four distinct phases of a migraine attack, including the premonitory stage, aura, throbbing pain, and a 'migraine hangover.'
  • The underlying cause of migraine is believed to be a brain disorder linked to various inherited gene mutations, with over 180 gene variants identified.
  • Disruption to daily routine, such as shifted sleep patterns or missing meals, hormonal changes, and dehydration are common migraine triggers.
  • Migraine is more prevalent in women, with three times more women affected than men, particularly during reproductive age.
  • Triptans remain a first-line treatment for migraine attacks, but some people experience side effects, and new classes of medications, such as small molecule CGRP inhibitors, have emerged.
  • Lifestyle measures, such as staying hydrated, exercising regularly, and getting enough sleep, can help prevent migraines.
  • New migraine prevention therapies, including CGRP inhibitors, have been developed for people with chronic migraine, and further research is ongoing to identify new prevention treatments.

Statistics:

  • 10 million people in the UK live with regular migraine attacks. (Source: NHS)
  • The annual economic impact of migraine-linked absenteeism from work is around £4.4 billion. (Source: NHS)
  • 18-25% of women suffer from migraine attacks. (Source: Prof MacGregor)
  • 1 in 3 migraine sufferers experience aura. (Source: Debbie Shipley, The Migraine Trust)
  • 0.01% of the population experiences hemiplegic migraine. (Source: Debbie Shipley, The Migraine Trust)
  • £15 per tablet is the cost of some CGRP inhibitors. (Source: Prof MacGregor)
  • 42-76% of people find triptans effective in relieving some symptoms of migraine attacks. (Source: Prof Loder, Harvard Medical School)

Sources:

  • NHS
  • Prof Anne MacGregor, Queen Mary University of London
  • Debbie Shipley, The Migraine Trust
  • Prof Loder, Harvard Medical School
  • Getty Images

Read more